3.684USD+1.77%Mkt Cap: 55.55M USDP/E: —Last update: 2026-05-26
Hyperion DeFi, Inc. operates as a digital asset treasury and ophthalmic technology company in the United States. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap55.55M USD
Enterprise Value46.26M USD
Revenue (TTM)1.04M USD
Gross Profit510.17K USD
Net Income (TTM)-45.31M USD
Revenue/Share0.1470 USD
Last Price3.684 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees9
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue44.36
P/S56.68
P/B0.76
EPS (TTM)-7.55
EPS (Forward)—
52W Range
1.40014% of range17.18
52W High17.18 USD
52W Low1.400 USD
Profitability
Gross Margin62.72%
Oper. Margin-2063.53%
EBITDA Margin0.00%
Profit Margin-5570.61%
ROE-110.36%
ROA-87.54%
Growth
Revenue Growth1559.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.77M USD
CapEx (TTM)71.95M USD
FCF Margin-722.83%
FCF Yield-13.57%
Net Debt1.69M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.21
Current Ratio1.97
Quick Ratio1.65
Book Value/Sh5.118 USD
Cash/Share0.6460 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:80
Split DateFeb 3, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)6.125 USD
Target Range4.000 USD – 8.250 USD
# Analysts2
Ownership
Shares Out.15.16M
Float11.04M
Insiders13.15%
Institutions10.66%
Short Interest
Short Ratio3.0d
Short % Float9.51%
Short % Out.9.11%
Shares Short1.04M
Short (prev mo.)1.21M
Technical
SMA 503.692 (-0.2%)
SMA 2005.176 (-28.8%)
Beta2.58
S&P 52W Chg28.31%
Avg Vol (30d)524.29K
Avg Vol (10d)576.00K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—